title: A case of chronic progressive myelopathy.
abstract: Acute myelitis and optic neuritis are the main clinical features of patients with neuromyelitis optica (NMO), which usually appears as a relapsing-remitting course of disease that worsens over days and improves over weeks. We present a patient with chronic progressive myelitis over a 4-month period without remission as having a limited form of NMO that improved after plasmapheresis. Plasmapheresis may benefit patients with chronic progressive myelitis, which may be a manifestation of NMO, as well as those with a relapsing-remitting course of NMO.
authors.affiliation: Department of Neurology, Seoul National University, College of Medicine, Seoul, Korea.
authors.forename: Jun-Soon
authors.initials: JS
authors.lastname: Kim
authors.forename: Young Ho
authors.initials: YH
authors.lastname: Park
authors.forename: Sung-Min
authors.initials: SM
authors.lastname: Kim
authors.forename: Su-hyun
authors.initials: SH
authors.lastname: Kim
authors.forename: Kyung Seok
authors.initials: KS
authors.lastname: Park
authors.forename: Jung-Joon
authors.initials: JJ
authors.lastname: Sung
authors.forename: Kwang-Woo
authors.initials: KW
authors.lastname: Lee
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D051401:Aquaporin 4 / Q000276:immunology; D001323:Autoantibodies / Q000032:analysis; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D053580:Muscle Strength / Q000502:physiology; D009460:Neurologic Examination; D009471:Neuromyelitis Optica / Q000188:drug therapy / Q000473:pathology* / Q000628:therapy; D010956:Plasmapheresis; D013116:Spinal Cord / Q000473:pathology
chemical_list: D000893:Anti-Inflammatory Agents; D051401:Aquaporin 4; D001323:Autoantibodies; D008775:Methylprednisolone